NEW C INNOVATION Trademark

Trademark Overview

On Monday, March 16, 2015, a trademark application was filed for NEW C INNOVATION with the United States Patent and Trademark Office. The USPTO has given the NEW C INNOVATION trademark a serial number of 86565358. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 4, 2025. This trademark is owned by New B Innovation Limited. The NEW C INNOVATION trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations, namely, prescription and over-the-counter medicines for the prevention and treatment of gastrointestinal and hepatobiliary system diseases, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormone related diseases, oncological diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear mouth and throat diseases, skin diseases, allergies and immune system diseases and for use as contraceptive agents, systemic anti-infectives, local and general anesthetics, antidotes, detoxifying agents and drugs used to treat substance dependence; Intravenous and other sterile solutions containing vitamin C, namely, intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Sanitary preparations for medical purposes; Whole blood, blood plasma, blood serum, red blood cells and hemoglob...
new c innovation

General Information

Serial Number86565358
Word MarkNEW C INNOVATION
Filing DateMonday, March 16, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 4, 2025
Registration Number5630215
Registration DateTuesday, December 18, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 2, 2018

Trademark Statements

Goods and ServicesPharmaceutical and veterinary preparations, namely, prescription and over-the-counter medicines for the prevention and treatment of gastrointestinal and hepatobiliary system diseases, cardiovascular and hematopoietic system diseases, respiratory system diseases, central nervous system diseases, musculo-skeletal system diseases, hormone related diseases, oncological diseases, genito-urinary system diseases, endocrine and metabolic system diseases, eye diseases, ear mouth and throat diseases, skin diseases, allergies and immune system diseases and for use as contraceptive agents, systemic anti-infectives, local and general anesthetics, antidotes, detoxifying agents and drugs used to treat substance dependence; Intravenous and other sterile solutions containing vitamin C, namely, intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Sanitary preparations for medical purposes; Whole blood, blood plasma, blood serum, red blood cells and hemoglobin solutions for medical purposes; Dietetic food and substances containing vitamin C, namely, food for babies; Oral preparations and medicinal herbs containing vitamin C for treatment and prevention of acute mountain sickness and adapted for medical or veterinary use; Medical plasters; Materials for dressings, namely, patches, gauzes, films, gels, foams, hydrocolloids, alginates, hydrogels and polysaccharide pastes, granules and beads; Material for stopping teeth; Dental wax; Disinfectants for hygienic purposes, medical instruments and sanitary purposes; Preparations for destroying vermin; Fungicides and herbicides
NOT AVAILABLE"C"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 4, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNew B Innovation Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHong Kong
HK
Party NameNew B Innovation Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHong Kong
HK
Party NameNew B Innovation Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHong Kong
HK

Trademark Events

Event DateEvent Description
Thursday, March 19, 2015NEW APPLICATION ENTERED
Wednesday, March 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 18, 2015ASSIGNED TO EXAMINER
Wednesday, June 24, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 24, 2015EXAMINER'S AMENDMENT ENTERED
Wednesday, June 24, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 24, 2015EXAMINERS AMENDMENT E-MAILED
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 17, 2015ASSIGNED TO LIE
Friday, July 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 4, 2015WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 24, 2015PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, September 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 21, 2016ASSIGNED TO LIE
Tuesday, March 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 19, 2016WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, May 2, 2016PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 9, 2017SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2017SOU EXTENSION 1 FILED
Thursday, February 9, 2017SOU EXTENSION 1 GRANTED
Thursday, August 10, 2017SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 5, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2017SOU EXTENSION 2 FILED
Thursday, August 10, 2017TEAS PETITION TO REVIVE RECEIVED
Thursday, August 10, 2017PETITION TO REVIVE-GRANTED
Friday, August 11, 2017NOTICE OF REVIVAL - E-MAILED
Tuesday, September 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 7, 2017SOU EXTENSION 2 GRANTED
Friday, September 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 30, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2018SOU EXTENSION 3 FILED
Tuesday, January 30, 2018SOU EXTENSION 3 GRANTED
Thursday, February 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 9, 2018SOU TEAS EXTENSION RECEIVED
Thursday, August 9, 2018SOU EXTENSION 4 FILED
Thursday, August 9, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, August 16, 2018SOU EXTENSION 4 GRANTED
Friday, August 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 23, 2018ASSIGNED TO PETITION STAFF
Saturday, August 25, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Saturday, August 25, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Tuesday, August 28, 2018NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 12, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 2, 2018PUBLISHED FOR OPPOSITION
Tuesday, October 2, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 18, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 18, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 4, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

innovation diseases system blood preparations used intravenous pharmaceutical agents namely other